72 related articles for article (PubMed ID: 24116377)
41. Characterization of chemoresistance mechanisms in a series of cisplatin-resistant transitional carcinoma cell lines.
Hour TC; Chen J; Huang CY; Guan JY; Lu SH; Hsieh CY; Pu YS
Anticancer Res; 2000; 20(5A):3221-5. PubMed ID: 11062746
[TBL] [Abstract][Full Text] [Related]
42. Tyrosine kinase receptor inhibitor-targeted combined chemotherapy for metastatic bladder cancer.
Wu CL; Ping SY; Yu CP; Yu DS
Kaohsiung J Med Sci; 2012 Apr; 28(4):194-203. PubMed ID: 22453067
[TBL] [Abstract][Full Text] [Related]
43. Effect of Herniarin on Cell Viability, Cell Cycle, and Erk Protein Levels in Different Stages of Bladder Cancer Cells.
Sanci TO; Terzi E; Oz Bedir BE; Gumustas M; Aydin T; Cakir A
Chem Biodivers; 2024 Mar; 21(3):e202301645. PubMed ID: 38235946
[TBL] [Abstract][Full Text] [Related]
44. In vivo photodynamic activity of hypericin in transitional cell carcinoma bladder tumors.
Zupkó I; Kamuhabwa AR; D'Hallewin MA; Baert L; De Witte PA
Int J Oncol; 2001 May; 18(5):1099-105. PubMed ID: 11295062
[TBL] [Abstract][Full Text] [Related]
45. Induction chemotherapy with cisplatin and cyclophosphamide and maintenance chemotherapy with doxorubicin and 5-FU in advanced urinary bladder tumors.
Sulkes A; Fuks Z
Cancer Treat Rep; 1983 Feb; 67(2):200-1. PubMed ID: 6681734
[No Abstract] [Full Text] [Related]
46. Protodynamic therapy for bladder cancer: in vitro results of a novel treatment concept.
Laihia JK; Pylkkänen L; Laato M; Boström PJ; Leino L
BJU Int; 2009 Nov; 104(9):1233-8. PubMed ID: 19466948
[TBL] [Abstract][Full Text] [Related]
47. Synergism of Fas-mediated apoptosis and tumor necrosis factor on adriamycin cytotoxicity to transitional cell carcinoma.
Yu DS; Hsieh DS; Chen HI; Chang SY
Urol Int; 2003; 70(3):161-6. PubMed ID: 12660450
[TBL] [Abstract][Full Text] [Related]
48. Comparative analysis of the cytotoxic effect of 7-prenyloxycoumarin compounds and herniarin on MCF-7 cell line.
Mousavi SH; Davari AS; Iranshahi M; Sabouri-Rad S; Tayarani Najaran Z
Avicenna J Phytomed; 2015; 5(6):520-30. PubMed ID: 26693409
[TBL] [Abstract][Full Text] [Related]
49. The combined effects of high-energy shock waves and cytostatic drugs or cytokines on human bladder cancer cells.
Wörle K; Steinbach P; Hofstädter F
Br J Cancer; 1994 Jan; 69(1):58-65. PubMed ID: 8286211
[TBL] [Abstract][Full Text] [Related]
50. Biosynthesis of coumarin and herniarin in lavender.
BROWN SA
Science; 1962 Sep; 137(3534):977-8. PubMed ID: 13873722
[TBL] [Abstract][Full Text] [Related]
51. Comparison of various techniques for the extraction of umbelliferone and herniarin in Matricaria chamomilla processing fractions.
Molnar M; Mendešević N; Šubarić D; Banjari I; Jokić S
Chem Cent J; 2017 Aug; 11(1):78. PubMed ID: 29086851
[TBL] [Abstract][Full Text] [Related]
52. Urinary Tract Tumor Organoids Reveal Eminent Differences in Drug Sensitivities When Compared to 2-Dimensional Culture Systems.
Wei Y; Amend B; Todenhöfer T; Lipke N; Aicher WK; Fend F; Stenzl A; Harland N
Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682984
[TBL] [Abstract][Full Text] [Related]
53. Combining a solution-phase derived library with in-situ cellular bioassay: prompt screening of amide-forming minilibraries using MTT assay.
Chiang LW; Pei K; Chen SW; Huang HL; Lin KJ; Yen TC; Yu CS
Chem Pharm Bull (Tokyo); 2009 Jul; 57(7):714-8. PubMed ID: 19571417
[TBL] [Abstract][Full Text] [Related]
54. Synthesis of umbelliferone derivatives in
Chu LL; Pandey RP; Lim HN; Jung HJ; Thuan NH; Kim TS; Sohng JK
J Biol Eng; 2017; 11():15. PubMed ID: 28396694
[TBL] [Abstract][Full Text] [Related]
55. BIOSYNTHESIS OF THE COUMARINS. VI. FURTHER STUDIES ON HERNIARIN FORMATION IN LAVENDER.
BROWN SA
Can J Biochem; 1965 Feb; 43():199-207. PubMed ID: 14325970
[No Abstract] [Full Text] [Related]
56. Umbelliferone instability during an analysis involving its extraction process.
Dawidowicz AL; Bernacik K; Typek R
Monatsh Chem; 2018; 149(8):1327-1340. PubMed ID: 30100630
[TBL] [Abstract][Full Text] [Related]
57. Coumarins inPrunus mahaleb and its herbivore, the small ermine mothYponomeuta mahalebellus.
Fung SY; Herrebout WM
J Chem Ecol; 1987 Oct; 13(10):2041-7. PubMed ID: 24301473
[TBL] [Abstract][Full Text] [Related]
58. Herniarin-loaded solid lipid nanoparticles: promising molecular mechanism and therapeutic potential against pancreatic cancer line.
Delkhah AMD; Karimi E; Farivar S
Mol Biol Rep; 2023 Aug; 50(8):6469-6479. PubMed ID: 37326747
[TBL] [Abstract][Full Text] [Related]
59. Enhancement of cisplatin cytotoxicity in combination with herniarin in vitro.
Haghighitalab A; Matin MM; Bahrami AR; Iranshahi M; Haghighi F; Porsa H
Drug Chem Toxicol; 2014 Apr; 37(2):156-62. PubMed ID: 24116377
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
